Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Precision Medicine in BRAF-Mutated Non–Small Cell Lung Cancer
EP. 1: Current Mutation Testing in Lung Cancer
December 22nd 2016
EP. 2: Understanding the BRAF-mutated Population in NSCLC
December 22nd 2016
EP. 3: Outcomes With Chemotherapy in BRAF-Mutant NSCLC
December 22nd 2016
EP. 4: Role of the MAP Kinase Pathway in NSCLC
December 22nd 2016
EP. 5: BRAF/MEK Efficacy in BRAF-mutant NSCLC
December 22nd 2016
EP. 6: NSCLC: The BRAF/MEK Combination Safety Profile
December 22nd 2016
EP. 7: The Evolving Mutational Landscape in NSCLC
December 22nd 2016
EP. 8: Patient Selection in BRAF-Mutant NSCLC
December 22nd 2016
EP. 9: Targeted Approaches in NSCLC: Lessons from Melanoma
December 22nd 2016
EP. 10: Practical Experience With Dabrafenib/Trametinib in NCSLC
December 22nd 2016
NEXT PAGE
<
1
2
>
PREVIOUS PAGE
x